» Articles » PMID: 23008321

Chronic Lymphocytic Leukemia After Chronic Myeloid Leukemia in the Same Patient: Two Different Genomic Events and a Common Treatment?

Citing Articles

High-Risk Chronic Lymphocytic Leukemia Complicating the Course of Imatinib-Treated Chronic Myeloid Leukemia: Successful Disease Management With Dual Tyrosine Kinase Inhibition.

James D, Green S, Molica S, Allsup D Case Rep Hematol. 2024; 2024:1813512.

PMID: 39583986 PMC: 11584251. DOI: 10.1155/2024/1813512.


[Both mother and daughter suffered from chronic myeloid leukemia and then the mother occurred secondary chronic lymphocytic leukemia: case report and literature review].

Wei Q, Wei Y, Wei X, Li X, Liu H, Feng R Zhonghua Xue Ye Xue Za Zhi. 2018; 39(5):423-424.

PMID: 29779355 PMC: 7342901. DOI: 10.3760/cma.j.issn.0253-2727.2018.05.016.


An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States.

Kumar V, Garg M, Chaudhary N, Chandra A PeerJ. 2018; 6:e4342.

PMID: 29456888 PMC: 5813591. DOI: 10.7717/peerj.4342.


Concomitant chronic myeloid leukemia and monoclonal B cell lymphocytosis - a very rare condition.

Duarte S, Pereira S, Rodrigues E, Pereira A Rev Bras Hematol Hemoter. 2017; 39(2):167-169.

PMID: 28577655 PMC: 5457473. DOI: 10.1016/j.bjhh.2017.02.004.


Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL).

Payandeh M, Sadeghi E, Khodarahmi R, Sadeghi M Int J Hematol Oncol Stem Cell Res. 2015; 8(4):49-53.

PMID: 25774268 PMC: 4345298.